Variations in p21 protein activity may cause poor myelin repair in multiple sclerosis. Reduced p21 activity is linked to diminished oligodendrocyte growth, especially in primary progressive multiple ...

President Ferdinand Marcos Jr. has ordered the immediate release of P21.47 billion in public funds to roll out fuel subsidies and sustain infrastructure projects, the Department of Budget and ...

President Ferdinand Marcos Jr. speaks before the 129th founding anniversary celebration of the Philippine Army at Fort Andres Bonifacio, Taguig City on March 19, 2026. — Screenshot from RTVM MANILA, ...

PRESIDENT Ferdinand Marcos Jr. ordered the Department of Budget and Management (DBM) to release P21.47 billion to sustain infrastructure projects, protect jobs and cushion Filipinos from the impact of ...

MANILA, Philippines — President Ferdinand Marcos Jr. ordered the Department of Budget and Management (DBM) to release P21.47 billion to sustain infrastructure projects, protect jobs, and cushion ...

The P21 peptide (also known as P021 in some literature) has recently attracted attention as a tool in molecular and cellular research. Although the peptide’s mechanisms remain under exploration, ...

Apoptosis, or programmed cell death, is a tightly regulated biological process necessary for normal tissue maintenance and development. However, aberrations in apoptotic signaling networks are ...

In Alzheimer's, brain cells die too soon. In cancer, dangerous cells don't die soon enough. That's because both diseases alter the way cells decide when to end their lives, a process called programmed ...

Cells in our body are programmed to die after a certain period of time—a natural process known as apoptosis or “cell suicide.” This process is essential for maintaining the body’s balance. When aged ...

Long noncoding RNAs (lncRNAs) have recently been implicated in many biological processes and diseases. Atherosclerosis is a major risk factor for cardiovascular disease. However, the functional role ...

Outcomes of patients with stage II/IIIA urothelial bladder cancer treated with systemic therapy: A 13-year single-center experience. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting ...